Found 13 matching trials
Clinical Trial of Brentuximab Vedotin in Classical Hodgkin Lymphoma PHASE2 This trial will study two treatment combinations for classical Hodgkin lymp...
Show More Location
Los Angeles Cancer Network / Compassionate Care Research Group
Learn More & Join Trial
Brentuximab Vedotin and Nivolumab in Treating Patients With Early Stage Classic Hodgkin Lymphoma PHASE2 This phase II trial studies how well brentuximab vedotin and nivolumab work...
Show More Status
Active Not Recruiting
Location
University of Alabama at Birmingham Cancer Center
Learn More & Join Trial
Comparison of AVD + Low-Dose Nivolumab vs. PET-Adapted BEACOPP-like in Advanced cHL PHASE2 Patients in this prospective multicenter phase II study will be randomized ...
Show More Location
A.N.Bakulev Center for cardiovascular surgery of the Russian Ministry of Health
Learn More & Join Trial
A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab PHASE3 This phase III trial compares the effect of adding immunotherapy (brentuxim...
Show More Location
Children's Hospital of Alabama
Learn More & Join Trial
Lowdose Nivolumab in Combination With AVD as Front Line Therapy for Classic Hodgkin's Lymphoma PHASE2 This study aims to prove the efficacy and safety of low dose nivolumab (40m...
Show More Location
Hospital Universitario Dr Jose Eleuterio Gonzalez
Learn More & Join Trial
A(B)VD Followed by Nivolumab as Frontline Therapy for Higher Risk Patients With Classical Hodgkin Lymphoma (HL) PHASE1 The aim of this study is to improve the chance of cure for people with high...
Show More Status
Active Not Recruiting
Location
Karmanos Cancer Institute
Learn More & Join Trial
Chemoradiotherapy With Targeted Immunotherapy in Pediatric Lymphoma PHASE2 The addition of targeted immunotherapy will be safe and well tolerated and ...
Show More Location
University of Alabama
Learn More & Join Trial
PET-Adapted First-Line Therapy With Nivolumab for Advanced Hodgkin Lymphoma PHASE2 This is a single-center, open-label, phase 2 pilot study evaluating the eff...
Show More Location
National Medical Research Center for Hematology
Learn More & Join Trial
Nivo40-AVD for Advanced Classic Hodgkin Lymphoma PHASE2 The aim of the current trial is to evaluate the efficacy and safety of flat...
Show More Location
P. Hertsen Moscow Oncology Research Institute (MORI) for administrative and economic work - the branch of the FSBI "National Medical Research Radiological Centre" (NMRRC) of the Ministry of Health of the Russian Federation
Learn More & Join Trial
Immunotherapy (Nivolumab or Brentuximab Vedotin) Plus Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage III-IV Classic Hodgkin Lymphoma PHASE3 This phase III trial compares immunotherapy drugs (nivolumab or brentuximab...
Show More Status
Active Not Recruiting
Location
Children's Hospital of Alabama
Learn More & Join Trial